116 related articles for article (PubMed ID: 3440233)
1. High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites.
Panza N; Lombardi G; De Rosa M; Pacilio G; Lapenta L; Salvatore M
Cancer; 1987 Nov; 60(9):2233-6. PubMed ID: 3440233
[TBL] [Abstract][Full Text] [Related]
2. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
3. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
Harish K
Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
[TBL] [Abstract][Full Text] [Related]
5. Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma.
Chung J; Kim EK; Lim H; Son EJ; Yoon JH; Youk JH; Kim JA; Moon HJ; Kwak JY
Head Neck; 2014 Jun; 36(6):795-801. PubMed ID: 23616395
[TBL] [Abstract][Full Text] [Related]
6. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification.
Shah DH; Dandekar SR; Jeevanram RK; Kumar A; Sharma SM; Ganatra RD
Acta Endocrinol (Copenh); 1981 Oct; 98(2):222-6. PubMed ID: 7293654
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
Biscontini G; Possa M; Sara R; Milella M; Rossetti C
Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
[TBL] [Abstract][Full Text] [Related]
9. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer.
Sands NB; Karls S; Rivera J; Tamilia M; Hier MP; Black MJ; Gologan O; Payne RJ
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):669-73. PubMed ID: 21144363
[TBL] [Abstract][Full Text] [Related]
11. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.
Pacini F; Fugazzola L; Lippi F; Ceccarelli C; Centoni R; Miccoli P; Elisei R; Pinchera A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1401-4. PubMed ID: 1592886
[TBL] [Abstract][Full Text] [Related]
12. [Value of the detection of serum thyroglobin and I-131 scintigraphy in the follow-up of differentiated thyroid cancer].
Ruiz Hernández G; Vázquez Forner C; Fliquete Peris MV
An Med Interna; 2000 Dec; 17(12):642-6. PubMed ID: 11213579
[TBL] [Abstract][Full Text] [Related]
13. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
[TBL] [Abstract][Full Text] [Related]
14. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases.
Snozek CL; Chambers EP; Reading CC; Sebo TJ; Sistrunk JW; Singh RJ; Grebe SK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4278-81. PubMed ID: 17684045
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
16. Cervical lymph node thyroglobulin measurement in washout of fine-needle aspirates for diagnosis of papillary thyroid cancer metastases.
Li J; Zhang K; Liu X; Hao F; Liu Z; Wang Z
Br J Biomed Sci; 2016; 73(2):79-83. PubMed ID: 27181176
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Serum Thyroglobulin Level as a Useful Predictive Marker to Differentiate Thyroid Cancer.
Kars A; Aktan B; Kilic K; Sakat MS; Gözeler MS; Yörük Ö; Mutlu V; Yılmaz S
ORL J Otorhinolaryngol Relat Spec; 2018; 80(5-6):290-295. PubMed ID: 30253396
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
[TBL] [Abstract][Full Text] [Related]
19. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
